The #RTIRE Trial is now recruiting patients with intermediate-risk prostate cancer.

”What is the RTIRE clinical trial aiming to achieve?”Подробнее

Prostate Cancer Clinical Trial: SABRE TrialПодробнее

Prostate Cancer Clinical Trial: RTIREПодробнее

”I have intermediate-risk prostate cancer — how can RT + IRE improve my treatment?”Подробнее

NRG GU010 Prostate Clinical Trail: 3-Part Video (full showcase in the description box)Подробнее

Genetic Testing in Prostate Cancer - Dr. Alexander Wyatt 2024 12Подробнее

Low, Intermediate & High Risk Prostate Cancer | Tucker Medical ShortsПодробнее

Intermediate Risk Prostate CancerПодробнее

Phase II trial of enoblituzumab for patients with intermediate/high-risk localised prostate cancerПодробнее

Prostate Cancer Clinical Trial: ESCAPE TrialПодробнее

Doctor Explains Cornell FORT Prostate Cancer Clinical TrialПодробнее

Focal Therapy for Men with Intermediate Risk Prostate CancerПодробнее

ProtecT Trial OverviewПодробнее

Prostate Cancer Clinical Trial NRG-GU010 (Part 1/3)Подробнее

Prostate Cancer Clinical Trial: Weill Cornell FORT TrialПодробнее

#ProstateCancer Clinical Trials: The Benefits and Risks | #MarkScholzMD #PCRIПодробнее

Prostate Cancer Clinical Trial NRG-GU010 (Part 2/3)Подробнее

Intermediate-Risk: Do You Need Hormone Therapy With Radiation? | #MarkScholzMD #AlexScholz #PCRIПодробнее

Recent Updates in #Molecular Imaging for #ProstateCancer #Clinical Trials #cancer #newsПодробнее